Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,081 | 1,175 | 1,343 | 1,550 | 1,591 | 1,859 | 2,299 | 3,282 | 3,524 | 3,241 | | 3,241 |
% Growth | NA | 8.7% | 14.2% | 15.5% | 2.6% | 16.9% | 23.6% | 42.8% | 7.4% | -8.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | (611) | (660) | (727) | (823) | (879) | (1,010) | (1,239) | (1,886) | (2,026) | (1,754) | | (1,754) |
Gross Profit | 470 | 515 | 615 | 727 | 712 | 850 | 1,060 | 1,396 | 1,498 | 1,487 | | 1,487 |
% Revenue | 43.5% | 43.8% | 45.8% | 46.9% | 44.7% | 45.7% | 46.1% | 42.5% | 42.5% | 45.9% | | 45.9% |
| | | | | | | | | | | | |
Research and Development | (106) | (107) | (107) | (118) | (121) | (136) | (168) | (229) | (277) | (316) | | (316) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (186) | (202) | (212) | (238) | (285) | (265) | (292) | (543) | (489) | (430) | | (430) |
Other Inc / (Exp) | (49) | (50) | (80) | (86) | 55 | (46) | (80) | (168) | (258) | (211) | | (211) |
Total Operating Exp | (341) | (358) | (399) | (442) | (351) | (448) | (540) | (940) | (1,024) | (958) | | (958) |
| | | | | | | | | | | | |
Operating Income | 129 | 157 | 216 | 285 | 360 | 402 | 520 | 456 | 473 | 529 | | 529 |
% Revenue | 11.9% | 13.3% | 16.1% | 18.4% | 22.6% | 21.6% | 22.6% | 13.9% | 13.4% | 16.3% | | 16.3% |
| | | | | | | | | | | | |
Interest Expense | (38) | (37) | (32) | (30) | (42) | (48) | (41) | (209) | (301) | (208) | | (208) |
Pre-tax Income | 90 | 120 | 185 | 254 | 318 | 354 | 479 | 247 | 172 | 321 | | 321 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (10) | (23) | (100) | (14) | (63) | (59) | (70) | (38) | 8 | (28) | | (28) |
Net Income to Company | 80 | 97 | 85 | 241 | 255 | 295 | 409 | 209 | 181 | 293 | | 293 |
% Margin | 7.4% | 8.3% | 6.3% | 15.5% | 16.0% | 15.9% | 17.8% | 6.4% | 5.1% | 9.0% | | 9.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 80 | 97 | 85 | 241 | 255 | 295 | 409 | 209 | 181 | 293 | | 293 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 80 | 97 | 85 | 241 | 255 | 295 | 409 | 209 | 181 | 293 | | 293 |
% Margin | 7.4% | 8.3% | 6.3% | 15.5% | 16.0% | 15.9% | 17.8% | 6.4% | 5.1% | 9.0% | | 9.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.57 | 0.69 | 0.60 | 1.71 | 1.89 | 2.19 | 3.02 | 1.47 | 1.21 | 1.94 | | 1.94 |
Diluted EPS (Continuing Ops) | 0.57 | 0.68 | 0.59 | 1.69 | 1.87 | 2.16 | 3.00 | 1.46 | 1.20 | 1.93 | | 1.93 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 140.35 | 141.09 | 141.55 | 141.03 | 135.14 | 134.84 | 135.41 | 142.29 | 149.90 | 150.95 | | 150.95 |
WA Diluted Shares Out. | 141.12 | 142.05 | 143.52 | 142.61 | 136.57 | 136.27 | 136.57 | 143.15 | 150.95 | 151.84 | | 151.84 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 90 | 120 | 185 | 254 | 318 | 354 | 479 | 247 | 172 | 321 | | 321 |
Addback: Net Interest Expense | 38 | 37 | 32 | 30 | 42 | 48 | 41 | 209 | 301 | 208 | | 208 |
Addback: Other Non Operating Expenses, Total | (7) | (1) | 2 | 6 | 1 | (9) | 8 | 21 | 7 | 11 | | 11 |
Addback: Depreciation & Amortization | 102 | 100 | 102 | 127 | 141 | 137 | 138 | 279 | 387 | 378 | | 378 |
Addback: Restructuring Charges | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 13 | 0 | 0 | 15 | (122) | 0 | 0 | 0 | 57 | 3 | | 3 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 6 | 13 | 0 | 0 | 0 | 0 | 0 | 30 | 13 | | 13 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 21 | 2 | 0 | 2 | 23 | 3 | (166) | (6) | | (6) |
Adjusted EBITDA | 232 | 262 | 355 | 436 | 381 | 532 | 690 | 759 | 904 | 928 | | 928 |
% Margin | 21.5% | 22.3% | 26.5% | 28.1% | 23.9% | 28.6% | 30.0% | 23.1% | 25.6% | 28.6% | | 28.6% |
| | | | | | | | | | | | |
Adjusted EBIT | 131 | 162 | 253 | 308 | 239 | 395 | 552 | 480 | 517 | 550 | | 550 |
% Margin | 12.1% | 13.8% | 18.8% | 19.9% | 15.0% | 21.3% | 24.0% | 14.6% | 14.7% | 17.0% | | 17.0% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 80 | 97 | 85 | 241 | 255 | 295 | 409 | 209 | 181 | 293 | | 293 |
Addback: Unusual Items | 9 | 6 | 35 | 18 | (122) | 2 | 23 | 3 | 36 | 11 | | 11 |
Less: Tax Benefit of Unusual Items (26%) | (2) | (2) | (9) | (5) | 32 | (1) | (6) | (1) | (9) | (3) | | (3) |
Adjusted Net Income | 87 | 102 | 111 | 254 | 165 | 297 | 426 | 211 | 208 | 301 | | 301 |
% Margin | 8.1% | 8.7% | 8.2% | 16.4% | 10.3% | 16.0% | 18.5% | 6.4% | 5.9% | 9.3% | | 9.3% |